Back to Agenda
Using Fast Healthcare Interoperability Resources (FHIR®) for Clinical Research
Session Chair(s)
Wayne R. Kubick, MBA
Chief Technology Officer
HL7 International, United States
While healthcare is rapidly adapting to the digital era, the basic systems and processes for conducting clinical studies to assess new medical treatments are still based on the legacy of a separate, paper-based, parallel process. EDC helped, but still was based on collecting data in a separate, siloed process disconnected from general healthcare practices.
Given the priorities of the FDA to incorporate real-world evidence from EHRs as eSource, coupled with industry pressure to reduce cost and time to market while reducing the burden on sites, the emergence and adoption of HL7 FHIR as a universal standard API that can make healthcare data readily available in a standard format for research purposes provides a provocative lever for reimagining research.
This session will examine the current state, readiness, and opportunities for applying FHIR to dramatically transform the research process.
Learning Objective : Discuss the basics of FHIR APIs, how they support goals of 21st Century Cures, and what FHIR can do for a variety of research-related use cases; Describe how experienced implementers worked with FHIR, and how the FHIR community is working to achieve interoperability among providers, investigators, researchers and patients.
Speaker(s)
Fast Healthcare Interoperability Resources: An Evolving Data Standard for Interoperability in the Life Sciences Industry
Kunal Dubey, MBA
CitiusTech Inc., United States
Associate Director
eSource and FHIR: The TransCelerate Experience
Jesper Kjær, MS
Novo Nordisk, Denmark
Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs
Have an account?